MAZE — Maze Therapeutics, Inc. stock price, charts and financials

QT39Maze Therapeutics, Inc.

Maze Therapeutics, Inc. (NASDAQ: MAZE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
27.61
+0.28+1.02%
OverviewShort InterestFilings
MAZEQT39Maze Therapeutics, Inc.·NASDAQ
27.61+1.02%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 20264Statement of changes in beneficial ownership
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 01, 2026144Notice of proposed sale of restricted securities
May 27, 20264Statement of changes in beneficial ownership
May 22, 20268-KCurrent report
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026144Notice of proposed sale of restricted securities
May 13, 2026EFFECTNotice of effectiveness
May 12, 202610-QQuarterly report
#1 / 25 of 182
Page
▼
/ 8